IBM Sinks 7% as CEO’s AI Spending Caution Overshadows Earnings Beat; Accenture and Infosys Ease Back
IBM (NYSE:IBM) shares fell 7% to $233.50 despite beating Q3 2026 revenue and EPS estimates. CEO Arvind Krishna's cautious AI spending remarks overshadowed results, keeping full-year revenue growth forecast unchanged at 4-5%. Software revenue rose 8%, but mainframe revenue dropped 20%. Accenture (NYSE:ACN) and Infosys (NYSE:INFY) also declined but less sharply.
How this was made

The 30-second read
Why it matters
The earnings release introduced new guidance and a stark AI‑spending caution, prompting immediate price pressure.
Market read
IBM's earnings and guidance shift moved the stock sharply, influencing broader tech sentiment.
What to watch
IBM's free cash flow guidance increase and Red Hat growth could support a rebound if AI concerns ease.
Background
IBM's Q3 2026 results topped estimates on revenue and EPS, but CEO Arvind Krishna warned that AI spending is being re‑evaluated by customers, leading to a 7% stock decline.
Ticker impact
IBM reported Q3 2026 earnings beat but kept full-year outlook unchanged, causing the stock to drop 7% in morning trading.
likely further downside as investors price in AI‑spending caution and unchanged revenue outlook
The 7% intraday decline reflects immediate market reaction; no new positive catalyst was provided.
Market effects
Technology sector ETFs (SPY, IYW) fell as AI‑spending concerns spread.
U.S. equity markets showed modest weakness in tech‑heavy indices.
Limited to U.S. markets; no immediate global macro effect.
Counterpoint
The earnings beat and strong cash flow raise the floor for IBM; the stock may be oversold on short‑term AI‑spending fears.
Key entities
- companyIBM
International Business Machines, provider of enterprise software, mainframes and consulting services.

